Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New phase III trial initiated for alicaforsen in Crohn's disease

Dec. 4, 2001

New substituted adenine interferon inducers under study by Japan Energy and Sumitomo

Nov. 30, 2001

Basiliximab: use in GI inflammatory disorders

Nov. 29, 2001

Hepatoprotectant ME-3738 appears to act via an IL-6-dependent mechanism

Nov. 29, 2001

Chiron grants nonexclusive HCV license to BMS

Nov. 29, 2001

Extensive coverage of ICN's second-generation ribavirin analogues at AASLD

Nov. 29, 2001

Tanabe Seiyaku improves pancreas selectivity of CCK-A receptor antagonists

Nov. 29, 2001

New gastric antisecretory agents designed by Byk Gulden

Nov. 26, 2001

AASLD news: Gilead's adefovir dipivoxil improves liver function and reduces viral load in HBV

Nov. 26, 2001

Rebetol receives Japanese approval for use in combination with Intron A for hepatitis C

Nov. 26, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...